RCAG
MED icon

Rehmann Capital Advisory Group’s Medifast MED Stock Holding History

Rehmann Capital Advisory Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$310 Buy
+3
New +$322 ﹤0.01% 1649

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Rehmann Capital Advisory Group's MED Position: Q3 2019 in Review

Rehmann Capital Advisory Group opened a new position in Medifast (MED) in Q3 2019: 3 shares worth $310. The stake represents ﹤0.01% of the portfolio and ranks #1649 among its holdings.

239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Rehmann Capital Advisory Group held 3 shares of Medifast worth $310 as of Q3 2019.
  • Medifast was a new Rehmann Capital Advisory Group position in Q3 2019.
  • Medifast made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1649 holding.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.